GlassScriptPhysician profile
Grace Nakamura
NPI 1639793110
$1,077.09
in general payments reported to CMS, 2019-2025
11 companies · $509 in 2025
The $509 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $247 · 2024: $321 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $221.70 | 2023-2024 | |
| Arcutis Biotherapeutics, INC. | $204.25 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $158.81 | 2024 | Sotyktu |
| Galderma Laboratories, L.P. | $150.00 | 2025 | Nemluvio |
| Pfizer INC. | $106.00 | 2023 | |
| Amgen INC. | $59.17 | 2023-2025 | Otezla, Otezla |
| Incyte Corporation | $49.51 | 2024 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $38.26 | 2025 | Dupixent |
| Genzyme Corporation | $36.73 | 2025 | |
| Abbvie INC. | $32.90 | 2025 | |
| Mayne Pharma Commercial LLC | $19.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Nakamura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.